Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | CRSR | Common Stock | Tax liability | -$10.9K | -800 | -0.39% | $13.57 | 205K | Jan 1, 2023 | Direct | |
transaction | CRSR | Common Stock | Tax liability | -$50.3K | -3.7K | -1.8% | $13.57 | 202K | Jan 2, 2023 | Direct | F1 |
transaction | CRSR | Common Stock | Sale | -$70K | -5K | -2.48% | $14.00 | 197K | Jan 4, 2023 | Direct | F1, F2 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | CRSR | Stock Option (Right to Buy) | Award | $0 | +258K | $0.00 | 258K | Feb 2, 2022 | Common Stock | 258K | $19.72 | Direct | F3, F4 |
Id | Content |
---|---|
F1 | Includes 51,592 restricted stock units. |
F2 | The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. |
F3 | This option was originally reported on a Form 4 filed by the Reporting Person on February 4, 2022. However, due to an inadvertent error, the Form 4 incorrectly reported the number of shares acquired. This option is being re-reported solely to correct the aforementioned error. Except as noted in this footnote, all other information as disclosed in the Reporting Person's original Form 4 was accurately reported. |
F4 | The options vest and become exercisable as to 25% of the total shares on January 2, 2023; and as to 1/48th of the total shares monthly thereafter, subject to continued service through each such vesting date. |